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Toxic megacolon as a rare complication
following atropine therapy due to
organophosphate poisoning: A case report
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Abstract
The main therapeutic basis for a case of organophosphate poisoning is a combination therapy which includes atropine as
an anticholinergic drug and pralidoxime. If the poisoning is severe, a high dose of this combination of medicines may be
needed, but this may cause serious side effects: paralytic ileus or even megacolon; however, these gastrointestinal events
are very rare. Here, we report a case of organophosphate poisoning where atropine therapy was given and led to drug-
associated toxic megacolon.
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Introduction
The treatment of organophosphate poisoning involves
a combination therapy that includes atropine as an
anticholinergic drug and pralidoxime.1 In some severe
poisoning cases, a high dose of this combination ther-
apy is needed which may cause the patient to suﬀer
serious side eﬀects including a paralytic ileus or even
megacolon, and patients with inﬂammatory bowel con-
ditions are particularly vulnerable.2 In other words,
severe dilatation of the colon may be reported follow-
ing the use of certain anticholinergic agents such as
atropine3; however, this complication is very rare. We
report a case of organophosphate poisoning where
treatment that included atropine therapy ﬁnally led to
drug-associated toxic megacolon.
Case presentation
The patient was a 52-year-old man who was referred to
the emergency ward of our hospital with loss of con-
sciousness and a history of consuming a known amount
of organophosphate pesticides within the last 24 h. On
admission, the patient was not responding to painful
stimuli and had no gag reﬂex. Because of abundant
airway and bronchial secretions, the patient was intu-
bated and connected to mechanical ventilation.
His vital signs included systolic/diastolic blood pressure
of 90/52mmHg, with a heart rate of 45 beats/min and
arterial oxygen saturation of 67%. On examination, he
did not respond to painful stimulus with bilateral
miotic pupils and bilateral absent plantar reﬂexes.
Pulmonary examination demonstrated coarse crackles
in all lung lobes. The abdomen was soft without disten-
sion. In initial echocardiography, the left ventricular
ejection was estimated to be 40%. After primary critical
supportive measures, a right subclavian vein line was
inserted and intravenous atropine 10mg was ordered
via this venous line that led to increase in heart rate
(125 beats per minutes) and O2 saturation (92%) with
limiting crackles to lung bases. The ﬁndings in initial
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arterial blood gas included PH of 7.59, PCO2 of
79mmHg, HCO3 of 18, and base excess of 10.
One litre of normal saline serum was ordered for the
patient, and the blood pressure was maintained at 105/
70mmHg. Two hours later, the arterial blood gas par-
ameters changed signiﬁcantly as a PH of 7.43, PCO2 of
55mmHg, HCO3 of 19, and base excess of 3.1. First
laboratory assessments, recorded: a white blood count
of 15,100/mm3 with neutrophil percentage of 86%,
serum haemoglobin level of 13.8 gr/dl, and platelet
count of 130,000/mm3. Regarding level of biomarkers,
CKMB was measured to be 48 and troponin to be 0.91.
The levels of serum magnesium was 1.9mg/dl, creatin-
ine 0.8mg/dl, calcium 8.5mg/dl, sodium 143mmol/L,
potassium 3.7mmol/L, AST 47mg/dl, ALT 23mg/dl,
CPK 423mg/dl, and serum cholinesterase 176 micro-
kat/l. The patient was treated with a combination of
atropine (2.5 to 3.5mg/h, intravenously), pralidoxime
(500mg/h, intravenously), along with bicarbonate 15
meq/day. On day 4 of hospitalisation, there were indi-
cations of megacolon in a chest X-ray (Figure 1). Liver
ultrasonography showed a fatty liver. In spiral multi-
slice lung CT (computed tomography) scan without
contrast (Figure 2), minimal pleural eﬀusion was evi-
dent in right hemithorax, and mild pneumothorax was
also found on the left side. Atelectasis was revealed at
the dependent portion of both lower lobes, and a small
consolidation with air bronchogram was evident in the
anterior of the right upper lobe suggesting pneumonia.
Spiral multislice abdomen and pelvic CT scan
(Figure 3) revealed: sigmoid colon dilatation with the
diameter up to 110mm in the left upper quadrant with
normal diameters of other portions of colon conﬁrming
a ﬁnal diagnosis of megacolon. No evidence of com-
plete obstruction was noted in the CT scan. No evi-
dence of sigmoid volvulus was found. The imaging of
other organs including kidneys, liver, spleen, pancreas,
and adrenals was normal. Maintenance therapy with
syrup of lactulose and rectal tube insertion was contin-
ued, and a percutaneous tracheostomy was performed
on day 10. About 20 days later, Electromyogram
(EMG)/Nerve Conduction Velocity (NCV) of quadri-
ceps muscles of the thigh was performed that seemed to
be normal. Atropine and pralidoxime were tapered
gradually. The level of serum cholinesterase reached
1803 and 3209 microkat/l in the days 26 and 33 after
treatment, respectively. The patient was taken oﬀ the
ventilator on day 30.
Comments
Some anticholinergic drugs and agents that can reduce
intestinal motility or delay intestinal transit time may
cause toxic megacolon.4 For this reason, Lomotil
(a combination of atropine and diphenoxylate) should
be used cautiously or even discontinued when
Figure 1. Evidences of megacolon on chest X-ray.
Figure 2. Spiral multislice lung CT scan without contrast indi-
cates minimal pleural effusion with mild pneumothorax and
atelectasis.
Figure 3. Spiral multislice abdomen and pelvic CT scan indicate
colon dilatation with megacolon diagnosis.
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abdominal distension occurs or if there is any evidence
of toxic megacolon as gastrointestinal symptoms and
side eﬀects are predictable with this drug. Adverse
eﬀects include inactivity of gastrointestinal peristalsis
that may lead to colon paralysis and even megacolon.5
The abdomen should therefore be monitored for dis-
tension and abdominal pain which should be followed
by imaging studies. Some previous studies indicate
there is an increased likelihood of megacolon following
atropine and as noted by Siegmund,6 patients treated
with atropine developed megacolon. This highlights the
importance of normally functioning ganglion cells
being present to prevent this condition. The patho-
physiological basis of megacolon following atropine
remains unclear; however, it seems to be associated
with delaying intestinal motility or the destruction of
intestinal ganglion cells.7
In our case, soon after atropine was administered,
there were clinical and imaging signs of megacolon, but
the EMG/NCV ﬁndings were normal.
Accordingly, the risk of developing megacolon
should be considered when prescribing atropine.
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